city Columbia covid-19 vaccine medicines city Columbia

Tonix to focus on precision medicine approaches for Covid-19

Reading now: 631
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Tonix Pharmaceuticals has signed a research collaboration and option agreement with Columbia University to explore precision medicine approaches for vaccines and therapeutics against Covid-19.

The partners will study the immune responses to Covid-19 in healthy volunteers who recovered from the disease or were asymptomatic.

The focus will be on T-cell and antibody responses at the cellular level. The research should help in better understanding of the detailed immune responses to the disease.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA